Literature DB >> 20549579

Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning for a child with recurrent anaplastic large cell lymphoma.

Hideaki Ohta1, Shigenori Kusuki, Hisao Yoshida, Emiko Sato, Yoshiko Hashii, Keiichi Ozono.   

Abstract

Anaplastic large cell lymphoma (ALCL) is chemosensitive, but recurrence is frequently observed. Allogeneic hematopoietic stem cell transplantation (HSCT) has recently been reported to be effective against recurrent disease, suggesting a graft-versus-lymphoma effect. We present a 3-year-old child with recurrent ALCL who underwent HSCT from an HLA-1-locus mismatched cord blood unit following reduced intensity conditioning with fludarabine, melphalan, and low-dose thoraco-abdominal irradiation. Engraftment was uneventful, but grade III acute graft-versus-host disease was observed. He is well and free of disease 25 months after HSCT, which implies that reduced intensity conditioning may allow a sufficient graft-versus-lymphoma effect against ALCL while lessening treatment-related toxicities.

Entities:  

Mesh：

Year:  2010        PMID： 20549579     DOI： 10.1007/s12185-010-0620-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


  19 in total

1.  Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma.

Authors:  Arcangelo Liso; Enrico Tiacci; Roberto Binazzi; Karen Pulford; Roberta Benedetti; Alessandra Carotti; Franco Aversa; Brunangelo Falini
Journal:  Lancet Oncol       Date:  2004-02       Impact factor: 41.316

2.  Successful treatment with allogeneic bone marrow transplantation of an early relapse of ALK-positive anaplastic large cell lymphoma.

Authors:  Victoria Bordon; Pascale De Paepe; Catharina Dhooge; Els Vandecruys; Yves Benoit; Genevieve Laureys
Journal:  Haematologica       Date:  2005-03       Impact factor: 9.941

3.  Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group.

Authors:  D Wright; P McKeever; R Carter
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

4.  Successful allogeneic stem cell transplantation for an adult with refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Authors:  Chao-Hsun Chen; Shan-Wen Chen; Wan-Lin Shen; Tsai-Yun Chen; Chao-Jung Tsao; Wen-Tsung Huang
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

5.  Recurrent childhood anaplastic large cell lymphoma: a retrospective analysis of registered cases in Japan.

Authors:  Tetsuya Mori; Tetsuya Takimoto; Naoyuki Katano; Akira Kikuchi; Ken Tabuchi; Ryoji Kobayashi; Hiroshi Ayukawa; Masa-aki Kumagai; Keizo Horibe; Masahito Tsurusawa
Journal:  Br J Haematol       Date:  2006-03       Impact factor: 6.998

6.  Relapses of childhood anaplastic large-cell lymphoma: treatment results in a series of 41 children--a report from the French Society of Pediatric Oncology.

Authors:  L Brugières; P Quartier; M C Le Deley; H Pacquement; Y Perel; C Bergeron; C Schmitt; J Landmann; C Patte; M J Terrier-Lacombe; G Delsol; O Hartmann
Journal:  Ann Oncol       Date:  2000-01       Impact factor: 32.976

7.  ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes.

Authors:  Lorena Passoni; Antonio Scardino; Carla Bertazzoli; Barbara Gallo; Addolorata M L Coluccia; François A Lemonnier; Konstadinos Kosmatopoulos; Carlo Gambacorti-Passerini
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

8.  Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report.

Authors:  Willi Woessmann; Christina Peters; Meike Lenhard; Birgit Burkhardt; Karl-Walter Sykora; Dagmar Dilloo; Bernhard Kremens; Peter Lang; Monika Führer; Thomas Kühne; Reza Parwaresch; Wolfram Ebell; Alfred Reiter
Journal:  Br J Haematol       Date:  2006-04       Impact factor: 6.998

9.  Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941.

Authors:  Eric J Lowe; Richard Sposto; Sherrie L Perkins; Thomas G Gross; Jonathan Finlay; David Zwick; Minnie Abromowitch
Journal:  Pediatr Blood Cancer       Date:  2009-03       Impact factor: 3.167

10.  Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.

Authors:  Thomas G Gross; Gregory A Hale; Wensheng He; Bruce M Camitta; Jean E Sanders; Mitchell S Cairo; Robert J Hayashi; Amanda M Termuhlen; Mei-Jie Zhang; Stella M Davies; Mary Eapen
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-30       Impact factor: 5.742
View more
  2 in total

1.  Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC.

Authors:  M Strullu; C Thomas; M-C Le Deley; A Chevance; J Kanold; Y Bertrand; C Jubert; J-H Dalle; C Paillard; A Baruchel; L Lamant; G Michel; L Brugières
Journal:  Bone Marrow Transplant       Date:  2015-03-30       Impact factor: 5.483

2.  Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma.

Authors:  Reiji Fukano; Tetsuya Mori; Naoto Fujita; Ryoji Kobayashi; Tetsuo Mitsui; Koji Kato; Ritsuro Suzuki; Junji Suzumiya; Takahiro Fukuda; Motohiro Shindo; Nobuo Maseki; Tatsu Shimoyama; Keiko Okada; Masami Inoue; Jiro Inagaki; Yoshiko Hashii; Atsushi Sato; Ken Tabuchi
Journal:  Int J Hematol       Date:  2019-10-16       Impact factor: 2.490
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.